Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics.

Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics.

Item
http://www.wikidata.org/entity/Q34606481
A polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrierEffect of dose-escalation of 5-fluorouracil on circadian variability of its pharmacokinetics in Japanese patients with Stage III/IVa esophageal squamous cell carcinomaFrom circadian rhythms to cancer chronotherapeutics.Pharmacokinetically guided dose adjustment of 5-fluorouracil: a rational approach to improving therapeutic outcomes.Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study.Circadian rhythm of dihydrouracil/uracil ratios in biological fluids: a potential biomarker for dihydropyrimidine dehydrogenase levels.Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipientsRelationship between 5-fluorouracil exposure and outcome in patients receiving continuous venous infusion with or without concomitant radiotherapy.The influence of circadian rhythms on the kinetics of drugs in humans.Implications of Circadian Rhythm Regulation by microRNAs in Colorectal CancerReplacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.Chimonanthus nitens var. salicifolius Aqueous Extract Protects against 5-Fluorouracil Induced Gastrointestinal Mucositis in a Mouse ModelA simple and rapid high-performance liquid chromatographic (HPLC) method for 5-fluorouracil (5-FU) assay in plasma and possible detection of patients with impaired dihydropyrimidine dehydrogenase (DPD) activity.Important role of the dihydrouracil/uracil ratio in marked interpatient variations of fluoropyrimidine pharmacokinetics and pharmacodynamics.Circadian time-effect of orally administered loratadine on plasma pharmacokinetics in mice.Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil.
P2860

Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics.

Item
http://www.wikidata.org/entity/Q34606481
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics.
@ast
Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics.
@en
Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics.
@nl
type
label
Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics.
@ast
Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics.
@en
Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics.
@nl
prefLabel
Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics.
@ast
Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics.
@en
Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698